| AAFP |
=
American Academy of Family Physicians |
| ACC |
=
American College of Cardiology |
| ACE |
=
angiotensin converting enzyme |
| ACEP |
=
American College of Emergency Physicians |
| ACLS |
=
advanced cardiac life support |
| AED |
=
automated external defibrillator |
| AF |
= atrial fibrillation |
| AFFIRM |
=
Atrial Fibrillation Follow-up Investigation of Rhythm Management |
| AHA |
= American Heart Association |
| ALS |
=
advanced life support |
| AMI |
=
acute myocardial infarction |
| AMI-SK |
=
Acute Myocardial Infarction-Streptokinase |
| ARB |
=
angiotensin receptor blocker |
| ARD |
=
absolute risk difference |
| ASSENT |
=
Assessment of the Safety and Efficacy of a New Thrombolytic
Regimen |
| ATP
III |
=
Adult Treatment Panel III report |
| AV |
=
atrioventricular |
| AVID |
=
Antiarrhythmics Versus Implantable Defibrillators |
| bpm |
=
beats per minute |
| CABG |
=
coronary artery bypass graft surgery |
| CAPRICORN |
=
Carvedilol Post-infarct Survival Controlled Evaluation |
| CAPRIE |
=
Clopidogrel vs. Aspirin in Patients at Risk of Ischemic Events |
| CAPTIM |
=
Comparison of Primary Angioplasty and Prehospital Thrombolysis
in the Acute Phase of Myocardial Infarction |
| CARE |
=
Cholesterol And Recurrent Events |
| CCP |
=
Cooperative Cardiovascular Project |
| CCS |
=
Canadian Cardiovascular Society |
| CCU |
=
coronary care unit |
| CHD |
=
coronary heart disease |
| CHF |
=
congestive heart failure |
| CI |
=
confidence interval |
| CK |
=
creatine kinase |
| C-PORT |
=
Cardiovascular Patient Outcomes Research Team |
| CPR |
=
cardiopulmonary resuscitation |
| CT |
=
computed tomography |
| CURE |
=
Clopidogrel in Unstable angina to prevent Recurrent Events |
| DANAMI |
=
DANish multicenter Trial in Acute Myocardial Infarction |
| DRS |
=
Diltiazem Reinfarction Study |
| DVT |
=
deep venous thrombosis |
| ECG |
=
electrocardiogram |
| ECMO |
=
extracorporeal membrane oxygenation |
| ED
|
=
emergency department |
| EMS |
= emergency medical services |
| EMT |
= emergency medical technician |
| EP |
= electrophysiology |
| EPHESUS |
= Eplerenone Post-Acute Myocardial Infarction Heart Failure
Efficacy
and Survival Study |
| GIK |
=
glucose-insulin-potassium |
| GISSI |
=
Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto
Miocardico |
| GP |
= glycoprotein |
| GUSTO |
=
Global Utilization of Strategies To Open occluded arteries |
| HDL-C
|
=
high-density lipoprotein cholesterol |
| HERO |
= Hirulog and Early Reperfusion or Occlusion trial |
| HERS
|
=
Heart and Estrogen/Progestin Replacement Study |
| HOPE |
=
Heart Outcomes Prevention Evaluation |
| hsCRP |
= high-sensitivity C-reactive protein |
| IABP
|
=
intra-aortic balloon pump |
| ICD
|
=
implantable cardioverter defibrillator |
| ICH |
= intracranial hemorrhage |
| IMA |
= internal mammary artery |
| InTIME
|
=
Intravenous nPA for Treatment of Infarcting Myocardium Early |
| ISIS
|
=
International Study of Infarct Survival |
| IV |
= intravenous |
| JNC-7
|
=
Seventh Joint National Committee on High Blood Pressure |
| LAD |
= left anterior descending coronary artery |
| LBBB
|
= left bundle-branch block |
| LDL-C |
= low-density lipoprotein cholesterol |
| LIPID |
= Long-Term Intervention With Pravastatin in Ischemic Disease |
| LMWH |
= low-molecular-weight heparin |
| LV |
=
left ventricular, left ventricle |
| LVAD |
= left ventricular assist device |
| LVEF |
=
left ventricular ejection fraction |
| MADIT |
=
Multicenter Automatic Defibrillator Implantation Trial |
| MAGIC |
= Magnesium in Coronaries trial |
| MDPIT |
= Multicenter Diltiazem Postinfarction Trial |
| MET |
= metabolic equivalent |
| MI |
= myocardial infarction |
| MR |
= mitral regurgitation |
| MUSTT |
= Multicenter Unsustained Tachycardia Trial |
| NASCET |
= North American Symptomatic Carotid Endarterectomy Trial |
| NCEP |
=
National Cholesterol Education Program |
| NHAAP |
=
National Heart Attack Alert Program |
| NHLBI
|
=
National Heart, Lung, and Blood Institute |
| NRMI |
= National Registry of Myocardial Infarction |
| NS |
= not significant |
| NSTEMI
|
= non–ST-elevation myocardial infarction |
| OR |
= odds ratio |
| PCI |
= percutaneous coronary intervention |
| PCWP |
= pulmonary capillary wedge pressure |
| PH |
= parenchymal hemorrhage |
| PRAGUE |
= PRimary Angioplasty in patients transferred from General community
hospitals to specialized PTCA Units with or without Emergency
thrombolysis |
| PRIMARY
CARE PROVIDER |
=
physician, nurse practitioner, physician assistant |
| RBBB |
= right bundle-branch block |
| REACT |
= Rapid Early Action for Coronary Treatment |
| RR |
= relative risk |
| RRR |
= relative risk reduction |
| RV
|
=
right ventricular, right ventricle |
| SAVE |
=
Survival and Ventricular Enlargement |
| SCD |
= sudden cardiac death |
| SHOCK |
= SHould we emergently revascularize |
| SPECT |
= single-photon emission computed tomography |
| STEMI |
= ST-elevation myocardial infarction |
| TEE |
= transesophageal echocardiography |
| TIA |
=
transient ischemic attack |
| TIMI |
= thrombolysis in myocardial infarction |
| TIMI
0 |
=
TIMI grade 0 flow, or no perfusion |
| TIMI
1 |
= TIMI grade 1 flow, or penetration without perfusion |
| TIMI
2 |
= TIMI grade 2 flow, or partial perfusion |
| TIMI
3 |
= TIMI grade 3 flow, or complete perfusion |
| TLC |
= Therapeutic Lifestyle Changes |
| tPA |
= tissue plasminogen activator |
| TRACE |
= Trandolapril Cardiac Evaluation |
| UA |
= unstable angina |
| UFH |
= unfractionated heparin |
| VALIANT
|
=
Valsartan in Acute Myocardial Infarction Trial |
| VF
|
=
ventricular fibrillation |
| VSR |
= ventricular septal rupture |
| VT |
= ventricular tachycardia |
| WARIS |
=
Warfarin-Aspirin Reinfarction Study |
| WHI
|
=
Women’s Health Initiative |
